title: Study of the effects of preparation containing ultralow doses of antibodies to S-100 protein in experimental hemorrhagic stroke.
abstract: Ultralow doses of antibodies to S-100 protein increased rat survival, reduced neurological deficit, eliminated myorelaxation, and improved movement coordination and cognitive functions in rats with experimental hemorrhagic stroke; the efficiency of the preparation was not inferior to that of nimodipine. In contrast to nimodipine, ultralow doses of antibodies to S-100 protein exhibited pronounced anxiolytic properties.
authors.affiliation: Materia Medica Holding Research-and-Production Company, Moscow.
authors.forename: T A
authors.initials: TA
authors.lastname: Voronina
authors.forename: I A
authors.initials: IA
authors.lastname: Kheyfets
authors.forename: Yu L
authors.initials: YL
authors.lastname: Dugina
authors.forename: S A
authors.initials: SA
authors.lastname: Sergeeva
authors.forename: O I
authors.initials: OI
authors.lastname: Epshtein
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use*; D020300:Intracranial Hemorrhages / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D009553:Nimodipine / Q000627:therapeutic use; D051381:Rats; D009418:S100 Proteins / Q000276:immunology*; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D000906:Antibodies; D009418:S100 Proteins; D014665:Vasodilator Agents; D009553:Nimodipine